Abstract
EPLIN is frequently downregulated or lost in various cancers. The purpose of this study was to evaluate the importance of EPLIN in prostate cancer progression, with particular focus on the mechanistic implications to elucidate EPLIN's tumor suppressive function in cancer. EPLIN expression was evaluated in prostate cancer cell lines and tissues. PC-3 and LNCaP EPLIN alpha overexpression models were generated through transfection with EPLIN alpha sequence and EPLIN knockdown was achieved using shRNA in CA-HPV-10 cells. Functional assays were performed to evaluate cellular characteristics and potential mechanisms were evaluated using a protein microarray, and validated using western blot analysis. EPLIN expression was reduced in clinical prostate cancer sections, including hyperplasia (p
Original language | English |
---|---|
Pages (from-to) | 2537-2550 |
Number of pages | 14 |
Journal | International Journal of Cancer |
Volume | 143 |
Issue number | 10 |
DOIs | |
Publication status | Published - 15 Nov 2018 |
Externally published | Yes |
Keywords
- EPLIN
- prostate cancer
- metastasis
- Src
- FAK
- FOCAL-ADHESION KINASE
- REGULATES ACTIN ORGANIZATION
- TYROSINE PHOSPHORYLATION
- CELL-MIGRATION
- MESENCHYMAL TRANSITION
- BREAST-CANCER
- CROSS-LINKING
- SRC
- PAXILLIN